Notice Number: NOT-HL-12-001
Key Dates
Release Date: January 10, 2012
Issued by
National Heart, Lung, and Blood Institute (NHLBI)
Purpose
On July 22, 2011, NHLBI issued a Notice (NOT-HL-11-154) in the NIH Guide discontinuing its participation in the Parent R21 Funding Opportunity Announcement (FOA). In brief, NHLBI will not accept any “new” R21s beginning with the 10/16/11 due date and beyond. However, the Institute will continue to accept resubmission (A1) R21 applications for the 3/16/12 due date for non-AIDS and for the 5/7/12 due date for AIDS R21s.
Since PA-10-069 has expired, NHLBI will participate in PA-11-261 for cycle I in 2012 in order to allow assignment of resubmission (A1) R21s to NHLBI for primary funding consideration. NHLBI will not accept any “new” (A0) R21 applications in response to the Parent R21 FOA (PA-11-261). Once cycle I (March 16/May 7) 2012 submissions are done, NHLBI will not accept any investigator-initiated R21 applications in response to PA-11-261.
All other aspects of PA-11-261 remain unchanged.
Inquiries
For general information and questions regarding the R21 program, individuals are encouraged to contact the appropriate scientific program Division within the NHLBI.
Interested parties may contact:
Division of Cardiovascular Diseases
Dr. Michael Lauer
Director
NHLBI/DCVD
Two Rockledge Center, Room 8124
6701 Rockledge Drive, MSC 7940
Bethesda, MD 20892-7940
Phone: 301-435-0466
Fax: 301-480-7971
Email: [email protected]
Dr. James Kiley
Director
NHLBI/DLD
Two Rockledge Center, Room 10042
6701 Rockledge Drive, MSC 7952
Bethesda, MD 20892-7952
Phone: 301-435-0233
Fax: 301-480-3547
Email: [email protected]
Dr. W. Keith Hoots
Director
NHLBI/DBDR
Two Rockledge Center, Room 9136
6701 Rockledge Drive, MSC 7950
Bethesda, MD 20892-7950
Phone: 301-435-0080
Fax: 301-480-0867
Email: [email protected]
and Human Services (HHS)
